eVenus Pharmaceutical Laboratories has recalled approximately 9,210 units of Desflurane, USP Liquid for Inhalation (240 mL) due to a defect where the containers may leak. This prescription medication, often used for general anesthesia, is manufactured by Shanghai Hengrui Pharmaceutical Co., Ltd. for Sandoz Inc. The recall affects specific lot numbers distributed in Colorado and was initiated after the discovery of the defective packaging.
The containers for the inhalation liquid may leak, which can lead to the unintended release of anesthetic vapor into the surrounding environment and potentially reduce the amount of medication available for the patient. Leaking anesthetic gases can pose a localized inhalation risk to healthcare providers or patients in the immediate vicinity of the defective bottle.
Standard FDA Drug Recall Remedy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.